Oct 22 (Reuters) - Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, reported an about 49 percent rise in quarterly profit as it benefited from the acquisition of genetic testing company Life Technologies .
February 2014 acquisition of Life Technologies should enhance the company ..... acquisitions. He thinks that the Life Technologies acquisition filled a number ..... Morozov also believes that the Life Technologies deal ultimately will be judged
chemicals. The company has a strong merger and acquisition record, and we think the February 2014 acquisition of Life Technologies should enhance the company's depth and scale in genetic sciences and biosciences, and provide a leadership position
We are dropping coverage of Life Technologies as it has been successfully acquired by Thermo Fisher Scientific following regulatory approval and is no longer a publicly traded company.
Life Technologies reported third-quarter results on Tuesday that fell in line with our projections as strength in research consumables and applied
Life Technologies LIFE reported mixed second-quarter results on Wednesday that were highlighted by adequate earnings growth despite weak academic
TMO (rating: BBB, narrow moat) agreed to buy Life Technologies , we downgraded its rating from A+ previously ..... rating: BBB, narrow moat) has agreed to buy Life Technologies , which led to Thermo's recent downgrade. Thermo
paid off handsomely this year, with top 25 stock holdings like Biogen, Medtronic MDT, Johnson & Johnson JNJ, and Life Technologies LIFE all up more than 25% since the start of 2013. The fund has also benefitted from its overweight position in
Life Technologies LIFE posted better-than-expected first-quarter results on Thursday, despite academic funding weakness and global macroeconomic
performance on the margin and earnings lines, with currency (mainly the Japanese yen) providing a headwind. The company suspended its share buyback program following last week's announcement of acquisition of Life Technologies LIFE.